Bag it up: new device aims to make fibroid surgery safer

NCT ID NCT03281460

Completed Disease control Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether using a special bag during laparoscopic fibroid removal (myomectomy or hysterectomy) can prevent the spread of cells that might be cancerous. Forty-eight women were randomly assigned to have the procedure with or without the bag. Researchers then checked the fluid in the abdomen for any stray muscle cells. The goal is to make minimally invasive fibroid surgery safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: More-cell-Safe AMI bag (device) for morcellation
What this could lead to: If it works, this could make laparoscopic fibroid surgery safer by reducing the risk of spreading potentially harmful cells.
What could go wrong: This is a small, early-stage trial with only 48 participants, so results may not apply to all patients. The bag may not prevent all cell spread and could add surgical time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYSTERECTOMY, VAGINAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

uterine corpus diffuse leiomyomatosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYSTERECTOMY, VAGINAL LAPAROSCOPY UTERINE MYOMATOSIS

Contacts and locations

Locations

Gynaecology Department, Hôpital Femme Mère Enfant

Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.